PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Nobuhiro Yuki Selected Research
Syndrome
02/2008
Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
01/2007
Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
01/2007
Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain-Barré syndrome.
12/2005
Immunoglobulin KM allotypes are associated with the prevalence of autoantibodies to GD1a ganglioside, but not with susceptibility to the disease, in Japanese patients with Guillain-Barré syndrome.
11/2004
[Axonal Guillain-Barré syndrome and physiological role of gangliosides in saltatory conduction of myelinated nerve fibers]
04/2004
Effect of methylprednisolone in patients with Guillain-Barré syndrome.
01/2004
Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
08/2003
CDR3 spectratyping analysis of the T cell receptor repertoire in Guillain-Barré and Fisher syndromes.
06/2003
Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barré syndrome onset subsequent to Campylobacter jejuni enteritis.
12/2002
Fisher syndrome or Bickerstaff brainstem encephalitis? Anti-GQ1b IgG antibody syndrome involving both the peripheral and central nervous systems.
10/2002
Fulminant Guillain-Barré syndrome after Campylobacter jejuni enteritis and monospecific anti-GT1a IgG antibody.
03/2002
Fine specificities of anti-LM1 IgG antibodies in Guillain-Barré syndrome.
01/2002
High anti-GM1 and anti-GD1a IgG antibody titers are detected in Guillain-Barré syndrome but not in chronic inflammatory demyelinating polyneuropathy.
Articles by Research Topic
Disease
13
Syndrome
02/2008 - 01/2002
3
Enteritis
06/2003 - 10/2002
2
Infection
02/2008 - 06/2003
2
Guillain-Barre Syndrome
01/2008 - 08/2004
1
Miller Fisher Syndrome (Fisher Syndrome)
07/2007
1
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
07/2006
1
Amyloidosis
05/2006
1
Encephalitis (Encephalitis, Rasmussen)
02/2004
1
Nervous System Diseases (Neurological Disorders)
03/2003
1
Progressive Bulbar Palsy (Fazio Londe Syndrome)
12/2002
1
Peripheral Nervous System Diseases (PNS Diseases)
12/2002
1
Ophthalmoplegia (External Ophthalmoplegia)
10/2002
1
Polyneuropathies (Polyneuropathy)
01/2002
Drug/Important Bio-Agent (IBA)
10
Immunoglobulin G (IgG)
IBA
02/2008 - 01/2002
6
Antibodies
IBA
02/2004 - 03/2002
4
Gangliosides
IBA
02/2008 - 11/2004
3
Immunoglobulin M (IgM)
IBA
07/2006 - 02/2004
2
sulfate-3-glucuronyl paragloboside
IBA
07/2006 - 05/2006
1
tebufenozide (Mimic)
IBA
07/2007
1
Monoclonal Antibodies
IBA
01/2007
1
Immunoglobulin A (IgA)
IBA
01/2007
1
rituximab (Mabthera)
FDA Link
07/2006
1
Autoantibodies
IBA
12/2005
1
GD1a ganglioside
IBA
12/2005
1
Immunoglobulin Km Allotypes
IBA
12/2005
1
G(M1) Ganglioside
IBA
08/2004
1
Methylprednisolone
FDA Link
Generic
04/2004
1
IV(4)-galactosyl-N-acetylganglioside GD1a
IBA
02/2004
1
ganglioside M1b (GM1b)
IBA
02/2004
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
08/2003
1
G(M2) Ganglioside (Ganglioside GM2)
IBA
03/2003